Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 mai 2012 10h05 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III Clinical Data at American Urological Association Annual Meeting

SAN DIEGO, May 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today a poster titled, "Updated analyses of...
26 avr. 2012 12h00 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Receives Notice of Issuance for First Prevonco(TM) Patent in the United States

SAN DIEGO, April 26, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the Company received an Issue...
22 mars 2012 07h00 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP

SAN DIEGO, March 22, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the European Patent Office...
14 mars 2012 10h05 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences, San Diego Hospice and The Institute for Palliative Medicine Announce a Broad Clinical Research Program Using NexACT(R) Technology

SAN DIEGO, March 14, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), San Diego Hospice (the "Hospice") and The Institute...
09 mars 2012 08h00 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO to Present at the 24th Annual ROTH OC Growth Stock Conference

SAN DIEGO, March 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that Bassam Damaj, Ph.D., Chairman, President and Chief Executive Officer, will...
08 mars 2012 14h21 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces 2011 Year End Financial Results Conference Call

SAN DIEGO, March 8, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that management will hold a conference call to discuss its 2011 year end financial...
06 mars 2012 10h00 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences CEO is Interviewed on CDTV.Net

SAN DIEGO, March 6, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) (www.apricusbio.com) Chief Executive Officer Dr. Bassam Damaj said in an interview on CDTV.net that his company has...
16 févr. 2012 10h06 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Shareholder Update With New Focus as a Commercially-Driven Specialty Pharmaceutical Company

SAN DIEGO, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today a corporate update to address Company activities and expected...
15 févr. 2012 12h36 HE | Source: Seelos Therapeutics, Inc.

Apricus Bioscience's Wholly-Owned Subsidiary NexMed (USA) Signs Exclusive German Collaboration for Vitaros(R) for Erectile Dysfunction

SAN DIEGO, Feb. 15, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly-owned subsidiary...
09 févr. 2012 09h29 HE | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Prices $20.0 Million Public Offering of Common Stock and Warrants

SAN DIEGO, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it has priced an underwritten public offering of 4,938,272...

Page précédente